In previous studies of resilience in people, researchers have rarely differentiated in their analysis between the types of traumatic events experienced by individuals. However, the type of trauma undergone seems to be a significant predictor of how...
For patients with diabetes, insulin is a life-saving medicine and an essential component of diabetes management, yet in the past decade alone, the out-of-pocket costs for insulin have doubled in the United States. One-quarter of patients with type 1 or 2...
For years, green has been the most reliable hue for live brain imaging, but after using a new high-throughput screening method, researchers at the John B. Pierce Laboratory and the Yale School of Medicine, together with collaborators at Stanford...
Endometriosis — a condition caused by uterine tissue growing outside of the organ — affects 10% of reproductive-aged women, whom it causes chronic pain that is significant and debilitating. The standard first-line treatment for all women with...
Despite the conventional belief that for women giving birth “once a cesarean always a cesarean,” the practice of attempting vaginal delivery after cesarean — also known as “trial of labor after cesarean delivery” (TOLAC) — is safe for many second-time...
Many top hospitals in the United States are making it unduly confusing or expensive for patients to gain access to their own medical records, say researchers at Yale. Their study appeared on Oct. 5 in JAMA Network Open.
Since the Health Insurance...
“Medicine and health sciences don’t exist in isolation from their broader social, cultural, and political contexts,” said Chelsea Clinton, vice chair of the Clinton Foundation, and adjunct assistant professor at the Columbia University Mailman School of...
Mothers and babies are dying due to birth-associated complications at higher rates now than a decade ago. In a new study appearing online in Birth, Katherine Campbell, assistant professor of obstetrics, gynecology and reproductive sciences at the Yale...
Three Yale researchers have won 2018 ‘High Risk, High Rewards’ grants from the Common Fund of the National Institutes of Health, which intends to fund “major opportunities and gaps in biomedical research that require trans-NIH collaboration to succeed.”...